APA (7th ed.) Citation

Rha, S. Y., Castanon, E., Gill, S., Senellart, H., Lopez, J., Márquez‐Rodas, I., . . . Villanueva, L. (2025). Lenvatinib plus pembrolizumab for patients with previously treated select solid tumors: Results from the phase 2 LEAP‐005 study recurrent glioblastoma cohort. Cancer (0008543X), 131(16), 1. https://doi.org/10.1002/cncr.70015

Chicago Style (17th ed.) Citation

Rha, Sun Young, et al. "Lenvatinib Plus Pembrolizumab for Patients with Previously Treated Select Solid Tumors: Results from the Phase 2 LEAP‐005 Study Recurrent Glioblastoma Cohort." Cancer (0008543X) 131, no. 16 (2025): 1. https://doi.org/10.1002/cncr.70015.

MLA (9th ed.) Citation

Rha, Sun Young, et al. "Lenvatinib Plus Pembrolizumab for Patients with Previously Treated Select Solid Tumors: Results from the Phase 2 LEAP‐005 Study Recurrent Glioblastoma Cohort." Cancer (0008543X), vol. 131, no. 16, 2025, p. 1, https://doi.org/10.1002/cncr.70015.